Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Greece Prevention, Early Intervention, And Digital Support Actions For The Mental Health Of Generation Z Within The Framework Of The Project Prevention, Early Diagnosis And Intervention Activities To Enhance The Mental Health Of Young People Of Generation Z (hea 2026-05-15
Germany Open House Drug Discount Agreements For The Active Ingredient Maraviroc, Atc J05ax09 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Peginterferon Beta-1a, Atc L03ab13 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Buserelin, Atc L02ae01 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Pazopanib, Atc L01ex03 For The Period January 1st, 2026 - December 31st, 2027 (plus Extension Option 1x12 Months) 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Tildrakizumab, Atc L04ac17 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Insulin Lispro, Atc A10ab04 And A10ad04 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Pazopanib, Atc L01ex03 For The Period 01.01.2026 - 31.12.2027 (plus Extension Option 1x12 Months) Pazopanib 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Buserelin, Atc L02ae01 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement For The Active Ingredient Insulin Lispro For The Period From January 1, 2026, To December 31, 2027. Insulin Lispro 2026-05-16
Whats app